| Date |
Name |
Affiliation |
Title
|
Abstract |
Recording |
Host |
|
|
October 7, 2026
|
Mortimer Poncz |
University of Pennsylvania |
“The Antiphospholipid Syndrome (APS) joins the PF4-Immunothrombotic Disorder Family.”
|
 |
|
Dr. Hugh Kim |
|
|
September 16, 2026
|
Antoine Dufour |
University of Calgary |
“The Mast Cells’ Greatest “substrate” Hits: Volume 1” |
 |
 |
Dr. Chris Overall |
|
| August 26, 2026 |
Rossi Lab |
SBME |
“Double feature: setting the homeostatic inflammatory environment/ LNP vaccines: the path from muscle to lymph node” |
 |
 |
Dr. Hugh Kim |
|
| August 19, 2026 |
Lai Lab |
CBR |
“Antiphospholipid syndrome in focus” |
 |
N/A |
Dr. Hugh Kim |
|
| August 5, 2026 |
Cheung Lab |
UBC/CBR |
“Engineering Injectable Biomaterials for Spinal Cord Repair: Design, Characterization, and Quantitative Evaluation” |
 |
N/A |
Dr. Hugh Kim |
|
| July 29, 2026 |
Cote Lab |
UBC/CBR |
“Unexpected turns encountered studying HIV and aging” |
 |
 |
Dr. Hugh Kim |
|
| July 22, 2026 |
Merkeley Lab |
UBC/CBR |
“Immune thrombocytopenia in the BC landscape”
|
 |
 |
Dr. Hugh Kim |
|
| July 8, 2026 |
Leitch Lab |
UBC/CBR |
“Management of Iron Overload in Adult Myelodysplastic Syndrome/A Short Introduction to the Role of Age & Frailty in Blood Cancers” |
 |
 |
Dr. Hugh Kim |
|
| June 24, 2026 |
Hedtrich Lab |
UBC/CBR |
“Development of CF Treatments Using Rationally-Designed Base Editors and Novel Pulmonary Administration Methods” |
 |
N/A |
Dr. Hugh Kim |
|
| June 17, 2026 |
McNagny Lab |
UBC/CBR |
“Innate Lymphoid Cells (ILCs) as therapeutic targets and cell based therapeutics for disease” |
 |
N/A |
Dr. Hugh Kim |
|
| June 10, 2026 |
Foster Lab |
UBC/CBR |
“Multi-omic analysis of bulk and single-cell data to understand biological function” |
 |
 |
Dr. Hugh Kim |
|
| June 3, 2026 |
Ma Lab |
UBC/CBR |
“New Bioanalytical Technologies to Investigate Cell Function” |
 |
N/A |
Dr. Hugh Kim |
|
| May 27, 2026 |
Jan Potempa |
University of Louisville |
“Modern Koch’s Postulates Applied to Bacterial Pathogenesis of Alzheimer’s Disease” |
 |
 |
Dr. Chris Overall |
|
| May 20, 2026 |
Eddie James |
Benaroya Research Institute |
“T Cell Responses to Self, Altered self and Pathobiont Epitopes in RA” |
 |
N/A |
Dr. Dieter Bromme |
|
| April 22, 2026 |
Ryan Stubbins |
BC Cancer |
“Transcriptional alterations drive disease relapse in acute myeloid leukemia” |
 |
N/A |
Dr. Hugh Kim |
|
| April 8, 2026 |
Angelo D’Alessandro
|
University of Colorado |
“High Throughput RBC Metabolism: From small molecules to Big Data and AI for Precision Metabolic Health.” |
 |
 |
Dr. Hugh Kim |
|
| March 4, 2026 |
Geraldine Walsh |
CBS |
“Blood bag sets: Preparing Canadian Blood Services for a DEHP-free (ish) future.” |
 |
 |
Dr. Hugh Kim |
|
| February 11, 2026 |
Jeff Dong |
UBC |
“Oxidized phosphatidylcholines mediate white matter and grey matter degeneration in multiple sclerosis.” |
 |
N/A |
Dr. Hugh Kim |
|
| January 28, 2026 |
Florian Kuchenbauer |
BC Cancer |
“Innovations and Insights in adverse-risk Acute Myeloid Leukemia” |
 |
N/A |
Dr. Hugh Kim |
|
| January 21, 2026 |
Marco Mara |
Michael Smith Laboratories |
“Towards Precision Cancer Genomic Medicine Resources for Canada: BC’s Personalized Oncogenomics Program and the Terry Fox Research Institute’s Marathon of Hope Cancer Centres Network” |
 |
 |
Dr. Hugh Kim |
|
| December 3, 2025 |
Dieter Fink |
BCCRI |
“The Integrated Mouse Modelling Services (IMMS) at the BC Cancer Research Institute – A Resource for Genome Editing Tools, and Transgenic and Reproductive Mouse Technology since 1993” |
 |
 |
Dr. Hugh Kim |
|
| November 19, 2025 |
Steve Hur |
University of North Carolina |
“The impact of quantitative and qualitative changes in fibrinogen on thrombosis and obesity” |
 |
N/A |
Dr. Hugh Kim |
|
| November 12, 2025 |
Craig Jenne |
University of Calgary |
“Immunothrombosis vs Thromboinflammation; Overlap, synergy and the application of proteomics” |
 |
 |
Dr. Kelly McNagny |
|
| October 22, 2025 |
Jerrold Levy |
Duke University |
“Thromboinflammation: From Bench to Bedside” |
 |
 |
Dr. Jay Kizhakkedathu |
|
| September 17, 2025 |
Dr. Michael Schmück-Henneresse |
Charité – Universitätsmedizin Berlin |
“Engineering T cells and organoid platforms for cancer immunotherapy, viral defense, and immune regulation” |
 |
N/A |
Sara Hedtrich |
|
| August 20, 2025 |
CBR Summer Series |
UBC |
“Factor X/Xa, the centre of the clotting universe” |
 |
 |
Pryzdial Lab |
|
| July 30, 2025 |
CBR Summer Series |
UBC |
“Leveraging the gut environment for functional biosensor probiotics” |
 |
|
Tropini Lab |
|
| July 23, 2025 |
CBR Summer Series |
UBC |
“Taste detection and processing in Drosophila“ |
 |
|
Gordon Lab |
|
| July 16, 2025 |
CBR Summer Series |
UBC and BCGSC |
“ Loss of FBXO11 function establishes a stem cell program in acute myeloid leukemia through dysregulation of LONP1″ |
|
 |
Karsan Lab |
|
| July 9, 2025 |
CBR Summer Series |
UBC |
“Towards Decentralized Diagnostics for Women’s Health Using Silicon Photonic Integrated Circuits” |
 |
|
Cheung Lab |
|
| July 2, 2025 |
CBR Summer Series |
UBC |
“In Situ Gene Editing to Rescue Severe Genetic Diseases of Human Epithelia” |
 |
|
Hedtrich Lab |
|
| June 25, 2025 |
CBR Summer Seminar Series |
UBC |
“Chronic Viral Infections and Inflammation in Women’s Health” |
 |
|
Cote Lab |
|
| June 18, 2025 |
CBR Summer Seminar Series |
UBC |
“Outlook for Single-Cell Proteomics and Lipidomics” |
 |
|
Foster Lab |
|
| June 12, 2025 |
Dr. James C. Zimring |
University of Virginia |
“Mechanisms and Sequelae of Alloimmunization to Transfused Platelets” |
 |
|
Dr. Hugh Kim |
|
| June 11, 2025 |
CBR Summer Seminar Series |
UBC |
“New Technologies to Investigate Cell Function” |
 |
|
Ma Lab |
|
| May 14, 2025 |
Dr. Blair R. Leavitt |
UBC |
“Developing Novel Gene Editing Therapies for Neurological Diseases” |
 |
 |
Dr. Hugh Kim |
|
| May 7, 2025 |
Dr. Stuart Turvey |
UBC |
“Learning From Our Patients: Discovery of New Human Monogenic Immune Disorders”
|
|
 |
Dr. Chris Overall |
|
| April 30, 2025 |
Dr. Samira Mubareka |
University of Toronto |
“Wild Things: Coronavirus in Canadian Wildlife”
|
 |
|
Dr. Chris Overall |
|
| April 23, 2025 |
Dr. Aly Karsan |
UBC |
“Non-genetic mechanisms of therapeutic sensitivity and resistance in the myeloid malignancies”
|
 |
|
Dr. Chris Overall |
|
| April 2, 2025 |
Dr. David Marchant |
University of Alberta |
“Structural insight into receptor usage, immune evasion, and evolution of a viral fusion glycoprotein”
|
 |
 |
Dr. Chris Overall |
|
| March 12, 2025 |
Dr. Yuan Yao |
UBC |
“Targeting extracellular microenvironment for modulating vascular cell behaviours”
|
 |
 |
Dr. Hongshen Ma |
|
| February 12, 2025 |
Dr. Phillip Domeier |
UBC |
“Protective and pathogenic paradigms of germinal centers”
|
 |
 |
Dr. Ed Pryzdial |
|
| December 4, 2024 |
Dr. Susan Shea |
University of Pittsburgh |
“Microfluidic Assays to Model Trauma and Transfusion Medicine”
|
 |
 |
Dr. Jay Kizhakkedathu |
|
| October 9, 2024 |
Dr. Yu (Seby) Chen |
BMB |
Michael John Page Ceremony & Presentation
|
 |
 |
Dr. Ross MacGillivray |
|
| October 2, 2024 |
Dr. Peter Friedl |
Radboud University Medical Centre |
“Tumor microenvironment and nutrient deprivation: plasticity of biomechanics, invasion and metastasis?”
|
 |
N/A |
Dr. Chris Overall |
|